Learn how to comply with the EU AI Act when AI is used in GCP-critical eTMF contexts in part two of this series by Donatella Ballerini.
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How A Dedicated Medical Affairs Team Drives Site Engagement
See how improvements made to SIP have allowed for quick access to study documents and bulk actions for streamlined document management and enhanced user experience.
-
Why Scalable EDC Systems Matter In Global Pharmaceutical Trials
Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.
-
Future Predictions For Clinical Technologies
In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
-
It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies
CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.
-
eTMF Systems Tell Compelling Story Of COVID-19 Vaccines
The rapid development of Covid-19 vaccines may lead more drug developers to increase their speed and agility by adopting electronic Trial Master File (eTMF) systems. In the case of Covid-19 vaccines, discover how eTMF systems tell a dramatic tale.
-
Control And Transparency: Solving Sponsors' Key Challenges In Study Launch
Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
-
Enhancing Information Dissemination
By utilizing advanced digital solutions, Medical Affairs (MA) teams can optimize workflows, reduce their operational burdens, and elevate the quality of communication.
-
What Is eCOA And How Does It Improve Clinical Trial Data Quality?
Discover how eCOA data capture can improve clinical trials by providing improved data quality, regulatory compliance, and accelerated clinical development.
-
Setting A New Client Standard In Study Closeout Timelines
Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
-
Increase Participant Diversity With eClinical Tools
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i
- 01.15.26 -- Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity